Cordis plans manufacturing capacity expansion in Ireland:
This article was originally published in Clinica
Executive Summary
Cordis has announced plans to build an 180,000ft2 manufacturing facility and new laboratories in Cashel, Ireland, to support the growing demand for its Cypher family of drug-eluting stents (DES). The facility, expected to be operational in the first half of 2008, will employ over 400 people, and the new labs would create 60 additional positions.